We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+0.65%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$73.9B
AUM Growth
-$2.32B
(-3%)
Cap. Flow
-$2.03B
Cap. Flow
% of AUM
-2.75%
Top 10 Holdings %
Top 10 Hldgs %
22.54%
Holding
3,088
New
92
Increased
1,359
Reduced
1,564
Closed
46
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$60.7M |
| 2 |
Analog Devices
ADI
|
+$46.1M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$37.3M |
| 4 |
Match Group
MTCH
|
+$28.2M |
| 5 |
GXO Logistics
GXO
|
+$19.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$89.3M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$78.9M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$77.4M |
| 4 |
Apple
AAPL
|
+$77M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$70.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.91% |
| 2 | Financials | 14.2% |
| 3 | Healthcare | 13.07% |
| 4 | Consumer Discretionary | 12.09% |
| 5 | Communication Services | 9.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1751
iShares Russell 1000 Growth ETF
IWF
$128B
| $2.6M | ﹤0.01% |
37,900
-116,288
| -75% | -$8.23M |
|
1752
Banc of California
BANC
$2.97B
| $2.59M | ﹤0.01% |
140,003
-16,484
| -11% | -$288K |
|
1753
DNOW Inc
DNOW
$2.99B
| $2.57M | ﹤0.01% |
335,868
-41,409
| -11% | -$338K |
|
1754
Coursera
COUR
$1.54B
| $2.56M | ﹤0.01% |
81,052
+64,607
| +393% | +$2.43M |
|
1755
eHealth
EHTH
$43.9M
| $2.56M | ﹤0.01% |
63,274
-12,834
| -17% | -$598K |
|
1756
FuelCell Energy
FCEL
$1.63B
| $2.56M | ﹤0.01% |
12,763
+123
| +1% | +$24.4K |
|
1757
Children's Place
PLCE
$59.8M
| $2.56M | ﹤0.01% |
34,040
-7,370
| -18% | -$653K |
|
|
WW
1758
DELISTED
WW International
WW
| $2.56M | ﹤0.01% |
139,979
-7,648
| -5% | -$200K |
|
|
MCHB
1759
Mechanics Bancorp
MCHB
$3.68B
| $2.55M | ﹤0.01% |
61,885
-9,539
| -13% | -$373K |
|
1760
Coherus Oncology
CHRS
$196M
| $2.54M | ﹤0.01% |
157,748
-27,601
| -15% | -$405K |
|
1761
Paysafe
PSFE
$375M
| $2.54M | ﹤0.01% |
27,255
+3,665
| +16% | +$420K |
|
|
CVAC
1762
DELISTED
CureVac
CVAC
| $2.53M | ﹤0.01% |
46,366
-222
| -0.5% | -$13.4K |
|
1763
BioLife Solutions
BLFS
$1.7B
| $2.53M | ﹤0.01% |
59,794
+36,767
| +160% | +$1.77M |
|
|
VISN
1764
Vistance Networks Inc
VISN
$2.52B
| $2.52M | ﹤0.01% |
185,824
-425
| -0.2% | -$7.3K |
|
1765
Schrodinger
SDGR
$1.36B
| $2.52M | ﹤0.01% |
46,060
+1,910
| +4% | +$122K |
|
1766
ICF International
ICFI
$1.72B
| $2.52M | ﹤0.01% |
28,176
+765
| +3% | +$69.5K |
|
1767
World Acceptance Corp
WRLD
$873M
| $2.51M | ﹤0.01% |
13,255
-1,214
| -8% | -$224K |
|
|
FLNA
1768
Filana Therapeutics
FLNA
$48.1M
| $2.51M | ﹤0.01% |
40,445
+643
| +2% | +$53.7K |
|
1769
Invesco Mortgage Capital
IVR
$805M
| $2.51M | ﹤0.01% |
79,690
-6,342
| -7% | -$206K |
|
1770
MP Materials
MP
$9.1B
| $2.5M | ﹤0.01% |
77,526
+7,886
| +11% | +$274K |
|
|
DHC
1771
Diversified Healthcare Trust
DHC
$2.14B
| $2.5M | ﹤0.01% |
736,027
-161,390
| -18% | -$609K |
|
|
FSR
1772
DELISTED
Fisker Inc.
FSR
| $2.5M | ﹤0.01% |
170,289
+3,892
| +2% | +$58.6K |
|
|
SWCH
1773
DELISTED
Switch, Inc. Class A Common Stock
SWCH
| $2.49M | ﹤0.01% |
98,110
+401
| +0.4% | +$9.41K |
|
|
ETWO
1774
DELISTED
E2open Parent Holdings
ETWO
| $2.49M | ﹤0.01% |
219,976
+163,679
| +291% | +$1.84M |
|
1775
Standard Motor Products
SMP
$911M
| $2.48M | ﹤0.01% |
56,845
-22,093
| -28% | -$948K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2021 Portfolio in Review
As of Q3 2021, RhumbLine Advisers held 3,088 positions worth $73.9B, down 3% from $76.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Trading was light in Q3 2021: portfolio turnover was 4.5%. RhumbLine Advisers opened 92 new positions and exited 46, leaving the 3,088-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q3 2021 buy was GXO Logistics: 250,722 shares worth $19.7M.
- RhumbLine Advisers added most to Moderna in Q3 2021, an estimated $60.7M increase.
- RhumbLine Advisers's biggest Q3 2021 reduction was Microsoft, cutting an estimated $89.3M.
- RhumbLine Advisers fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $77.4M.
- RhumbLine Advisers's ten largest holdings make up 23% of its $73.9B portfolio in Q3 2021.
- RhumbLine Advisers opened 92 new positions and closed 46 in Q3 2021.
- RhumbLine Advisers's portfolio value fell 3% quarter-over-quarter to $73.9B.
Based on RhumbLine Advisers's 13F filing for Q3 2021, filed 12 Nov 2021.